BRPI0516922A - composto de ribavirina, método para fazer um composto de ribavirina, método para usar um composto de ribavirina e composição farmacêutica - Google Patents
composto de ribavirina, método para fazer um composto de ribavirina, método para usar um composto de ribavirina e composição farmacêuticaInfo
- Publication number
- BRPI0516922A BRPI0516922A BRPI0516922-4A BRPI0516922A BRPI0516922A BR PI0516922 A BRPI0516922 A BR PI0516922A BR PI0516922 A BRPI0516922 A BR PI0516922A BR PI0516922 A BRPI0516922 A BR PI0516922A
- Authority
- BR
- Brazil
- Prior art keywords
- ribavirin
- ribavirin compound
- compound
- making
- pharmaceutical composition
- Prior art date
Links
- 229960000329 ribavirin Drugs 0.000 title abstract 9
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title abstract 9
- -1 ribavirin compound Chemical class 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
COMPOSTO DE RIBAVIRINA, MéTODO PARA FAZER UM COMPOSTO DE RIBAVIRINA, MéTODO PARA USAR UM COMPOSTO DE RIBAVIRINA E COMPOSIçãO FARMACêUTICA. A presente invenção refere-se a sistemas de liberação de ribavirina e mais especificamente a composições que compreendem amino ácidos, como amino ácidos ou peptídeos individuais, covalentemente ligados à ribavirina e a métodos para administrar composições de ribavirina conjugada.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62385704P | 2004-11-02 | 2004-11-02 | |
| PCT/US2005/039621 WO2006050421A1 (en) | 2004-11-02 | 2005-11-02 | Prodrugs of ribavirin with improved hepatic delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0516922A true BRPI0516922A (pt) | 2008-09-23 |
Family
ID=36319525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0516922-4A BRPI0516922A (pt) | 2004-11-02 | 2005-11-02 | composto de ribavirina, método para fazer um composto de ribavirina, método para usar um composto de ribavirina e composição farmacêutica |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20080260691A1 (pt) |
| EP (1) | EP1812039A1 (pt) |
| JP (1) | JP2008522959A (pt) |
| KR (1) | KR20070085544A (pt) |
| CN (1) | CN101374539A (pt) |
| AU (1) | AU2005302162A1 (pt) |
| BR (1) | BRPI0516922A (pt) |
| CA (1) | CA2586064A1 (pt) |
| IL (1) | IL182941A0 (pt) |
| WO (1) | WO2006050421A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1917037A2 (en) * | 2005-08-15 | 2008-05-07 | F.Hoffmann-La Roche Ag | Peg-ifn alpha and ribavirin for hbv treatment |
| GB0614034D0 (en) * | 2006-07-14 | 2006-08-23 | Iqur Ltd | Antiviral compounds |
| TWI459947B (zh) | 2007-06-26 | 2014-11-11 | Otsuka Pharma Co Ltd | 苯并氮呯化合物及藥學製劑 |
| PL2352497T3 (pl) | 2008-10-31 | 2017-08-31 | University Of Mississippi | Proces przygotowania estrów aminokwasowych delta-9-thc |
| JP5656399B2 (ja) * | 2008-12-26 | 2015-01-21 | 大塚製薬株式会社 | 医薬及び医薬製剤 |
| JP2018076280A (ja) * | 2016-10-28 | 2018-05-17 | 国立大学法人 大分大学 | ジカウイルス感染症治療用医薬組成物 |
| JP6859559B2 (ja) * | 2017-03-16 | 2021-04-14 | 二村 芳弘 | 抗アレルギー作用を呈するフェニルペプチド誘導体 |
| CN111320662B (zh) * | 2020-02-17 | 2022-11-25 | 南京医科大学 | 一类n-苄基取代的二脒那秦衍生物及其药物用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6340696B1 (en) * | 1999-03-31 | 2002-01-22 | The Procter & Gamble Company | Viral treatment |
-
2005
- 2005-11-02 US US11/718,311 patent/US20080260691A1/en not_active Abandoned
- 2005-11-02 KR KR1020077012139A patent/KR20070085544A/ko not_active Withdrawn
- 2005-11-02 BR BRPI0516922-4A patent/BRPI0516922A/pt not_active Application Discontinuation
- 2005-11-02 WO PCT/US2005/039621 patent/WO2006050421A1/en not_active Ceased
- 2005-11-02 CN CNA2005800454554A patent/CN101374539A/zh active Pending
- 2005-11-02 CA CA002586064A patent/CA2586064A1/en not_active Abandoned
- 2005-11-02 JP JP2007540395A patent/JP2008522959A/ja not_active Withdrawn
- 2005-11-02 EP EP05825005A patent/EP1812039A1/en not_active Withdrawn
- 2005-11-02 AU AU2005302162A patent/AU2005302162A1/en not_active Abandoned
-
2007
- 2007-05-02 IL IL182941A patent/IL182941A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1812039A1 (en) | 2007-08-01 |
| CA2586064A1 (en) | 2006-05-11 |
| CN101374539A (zh) | 2009-02-25 |
| US20080260691A1 (en) | 2008-10-23 |
| AU2005302162A1 (en) | 2006-05-11 |
| KR20070085544A (ko) | 2007-08-27 |
| JP2008522959A (ja) | 2008-07-03 |
| IL182941A0 (en) | 2007-09-20 |
| WO2006050421A1 (en) | 2006-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA94942C2 (ru) | Фармацевтические композиции с ингибиторами dpp iv | |
| CY1118038T1 (el) | Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος | |
| NO20090875L (no) | Fusjonspeptid for inhibenng av interaksjon mellom neuronal NMDA-reseptor og NMDAR-mteragerende proteiner | |
| ATE534383T1 (de) | Zusammensetzungen aus n-ä2,4-bis(1,1- dimethylethyl)-5-hydroxyphenylü-1,4-dihydro-4- oxochinolin-3-carboxamid | |
| CY1118731T1 (el) | Φαρμακευτικες συνθεσεις αλβιγλουτιδης | |
| CR10124A (es) | Formulaciones orales que comprenden tigeciclina | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| BRPI0809366B8 (pt) | polipeptídeo substancialmente alfa-helicoidal, método para fabricação do mesmo, aminoácido e composição farmacêutica | |
| EA200802166A1 (ru) | Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью | |
| MY169272A (en) | Her2 antibody composition | |
| BRPI0513178A (pt) | composições para distribuir fármacos altamente solúveis em água | |
| EP1881020A4 (en) | POLYMERIC DERIVATIVE OF A METABOLIC ANTAGONIST OF CYTIDINE | |
| WO2007138116A3 (de) | Pharmazeutische zusammensetzung zur behandlung von virusinfektionen und/oder tumorerkrankungen durch inhibition der proteinfaltung und des proteinabbaus | |
| EA200802128A1 (ru) | Новые нутрицевтические композиции | |
| BRPI0713031B8 (pt) | composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos | |
| BRPI0516577A (pt) | agentes terapêuticos com toxicidade diminuìda | |
| WO2008093058A3 (en) | Peptides and their use | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| ATE491349T1 (de) | Neue nutrazeutika-zusammensetzungen | |
| DE602004014145D1 (de) | Von rasgap-abgeleitetes peptid zur gezielten tötung von krebszellen | |
| BRPI0414008B8 (pt) | compostos que se ligam a um receptor de trombopoietina, composições e métodos in vitro para ativação de um receptor de trombopoietina em uma célula | |
| WO2009047513A3 (en) | Antagonists of kisspeptin and uses thereof | |
| CY1110040T1 (el) | Παραγωγα μεξοτρεξατης που δεσμευουν πρωτεϊνες και φαρμακευτικα μεσα που τα περιεχουν | |
| ATE552832T1 (de) | Antidepressivum-propharmaka | |
| CY1109541T1 (el) | Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: SHIRE LLC (US) Free format text: TRANSFERIDO POR FUSAO DE: NEW RIVER PHARMACEUTICALS INC. |
|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |